ABOUT
Glacier Bio
Glacier Bio partners with life sciences organizations—from startups to big pharma—to provide best-in-class leadership, guidance, and expertise in pre-clinical and clinical study design and management. Our goal is to deliver solutions that help teams, organizations, and the industry grow, thrive, and in turn, transform health care delivery.
We pair our full-time staff of top talent with tomorrow’s big breakthroughs and today’s leaders, guiding growth, integration, and sustainable success from R&D through approvals, production and decommissioning. Our team members are industry professionals who support mission-critical projects and operations by rolling up their sleeves and working side-by-side with our partners toward solutions.
Our Team
Marshelle Warren, M.D.
B.S. in Biology from Baylor University. M.D. from University of Nebraska Medical School. Experience at Astra Zeneca, Immunex, Amgen, Gilead, Atara and most recently at Viracta Therapeutics
Research and Development leadership advancing epigenetic approachs to treat viral malignancies and platforms to synergize with immunotherapy. Experienced in heading Research and Development, Scientific Advisory Boards, Presentations to Board of Directors and Fund Raising.
Immuno-oncology, T-cell Therapy, Biologics, Antisense Oligonucleotides and Small Molecules.
Immunology, Oncology, Autoimmune, Viral and Rare Diseases. Four successfully approved products including blockbuster Enbrel with sales in excess of 50B.
Adair Clayton
Adair received his B.S. in Microbiology from the University of Washington in 2019. His broad biological research experience includes development of HIV diagnostics, R&D of EBV+ malignancy treatments, and genetic analysis of intestinal microbiota.
Within the Posner Research Group at the University of Washington, Adair aided in the experimentation and anlysis of a novel Nucleic Acid Amplification Technique that can pioneer new Point of Care diagnostics in resource limited settings. Isotachophoresis (IT) combined Recombinant Polymerase Amplification (RPA) within a paper-based microfluidic device can identify HIV RNA from blood samples to diagnose and monitor treatment significantly quicker and cheaper than current methods. Adair gained experience in general lab safety and maintenance, nucleic acid based experimental design, RNA and DNA isolation, concentration and amplification techniques, photomicroscopy, and coding in MATLAB. This work pushed his critical thinking skills to perform experiments with a specific question to be answered and understanding of the progression of how the results will produce new questions to be answered.